+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Muellerian inhibiting substance mis blocks autophosphorylation of the egf receptor a possible molecular mechanism of action of mis as an inhibitor of tumor cell growth



Muellerian inhibiting substance mis blocks autophosphorylation of the egf receptor a possible molecular mechanism of action of mis as an inhibitor of tumor cell growth



Investigational New Drugs: 90




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028753093

Download citation: RISBibTeXText


Related references

Muellerian inhibiting substance blocks autophosphorylation of the egf receptor by inhibiting tyrosine kinase. Molecular & Cellular Endocrinology 49(1): 75-86, 1987

SU5416 A potent and selective Flk-1/KDR kinase inhibitor that blocks receptor autophosphorylation, endothelial cell mitogenesis, and tumor growth. Abstracts of Papers American Chemical Society 215(1-2): MEDI 205, 1998

Mechanism of action of muellerian inhibiting substance. Berne, R M (Ed ) Annual Review Of Physiology, Vol 46 Ix+727p Annual Reviews, Inc : Palo Alto, Calif , Usa Illus P53-66, 1984

Antibody against avian muellerian inhibiting substance mis recognizes mis on rat muellerian duct and human tumor cells. Proceedings of the National Science Council Republic of China Part B Life Sciences 13(4): 267-275, 1989

The binding of muellerian inhibiting substance mis and growth hormone gh on chick muellerian duct md corresponds to ductal regression and growth. Journal of Cell Biology 105(4 Part 2): 12A, 1987

Human muellerian inhibiting substance inhibits tumor growth in vitro and in vivo. Cancer Research 51(8): 2101-2106, 1991

Programmed cell death in the muellerian duct induced by muellerian inhibiting substance. American Journal of Anatomy 149(3): 353-376, 1977

Muellerian inhibiting substance as oocyte meiosis inhibitor. Molecular & Cellular Endocrinology 47(3): 225-234, 1986

Muellerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay. Gynecologic Oncology 22(2): 135-148, 1985

Muellerian inhibiting substance demonstration of receptor deficiency. Clinical Research 29(1): 109A, 1981

The correlation of glycolization in muellerian inhibiting substance and its activity for muellerian duct regression. Journal Of Cell Biologypart 2: 38a, 1983

Involution of the muellerian duct under the influence of the muellerian inhibiting substance in an organ culture assay. Anatomical Record 193(3): 657-658, 1979

Insensitivity of the chick embryo muellerian duct to human recombinant muellerian inhibiting substance. Journal of Molecular Endocrinology 8(1): 73-78, 1992

Muellerian inhibiting substance receptor characterization with an anti idiotypic antibody. Journal of Urology 139(4 Part 2): 434A, 1988

Mullerian inhibiting substance blocks epidermal growth factor receptor phosphorylation in fetal rat lung membranes. Metabolism Clinical & Experimental 40(11): 1178-1184, 1991